Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Nicotinamide in the Treatment of Psoriasis [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluating nicotinamide for treating psoriasis.
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks [Phase 2]
Phase 2 safety and efficacy study of a non-steroid topical cream for psoriasis has completed (12 weeks).
-
CLINICAL_TRIALS trial_result · 2012-12-19Clinical Trial Update: A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis [Phase 2]
This entry summarizes the results of a Phase 2 safety and effectiveness study of CNTO 1275 in adults with moderate to severe plaque-type pso…
-
CLINICAL_TRIALS trial_result · 2012-12-19Clinical Trial Update: Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
A Phase 2 trial evaluating three dosing regimens of CP-690,550 (tofacitinib) versus placebo for efficacy and safety in adults with moderate-…
-
FDA label_change · 2012-12-07FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, Inc., updating the product labeling. This…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Comparing the Efficacy of Ultravate Ointment in Combination With Lac-Hydrin Lotion in the Treatment of Psoriasis [Phase 4]
Phase 4 trial comparing Ultravate ointment plus Lac-Hydrin lotion for stable plaque psoriasis has completed with results posted in 2012.
-
FDA approval · 2012-11-30FDA Approved: CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Calcipotriene and Betamethone Dipropionate submitted by Prasco Laboratories. It pertains to the …
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis
A Pfizer-sponsored observational study completed to assess how common undiagnosed psoriatic arthritis is among patients with plaque psoriasi…
-
FDA approval · 2012-11-26FDA Approved: BETAMETHASONE VALERATE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a generic topical betamethasone valerate product from Padagis Israel Pharmaceuticals Ltd (Original Application).
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: The Efficacy Of A Dead Sea Mineral Enriched Body Cream vs Its Carrier as an Adjuvant Treatment For Psoriatic Patients
A clinical trial evaluating the efficacy of Dead Sea Mineral Enriched Body Cream as an adjuvant treatment for psoriasis compared with its ca…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis [Phase 3]
Phase 3 study assessing safety and efficacy of ustekinumab (CNTO 1275) in moderate to severe psoriasis; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis [Phase 1]
A Phase 1 clinical pharmacology study of KHK4827 in healthy volunteers and patients with moderate to severe psoriasis, which has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-29Clinical Trial Update: Assessment of Long-Term Infliximab for Psoriasis (P05319)
This entry reports the long-term evaluation of infliximab for psoriasis in a completed clinical trial, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris. [Phase 1]
Phase 1 trial assessing narrowband UVB light therapy in dark-skinned patients with 10% body involvement of psoriasis vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis
This clinical trial update reports on the effectiveness and safety of TNF inhibitors in adults with moderate to severe psoriasis, with resul…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis [Phase 3]
Phase 3 trial evaluating the safety and efficacy of ustekinumab in Korean and Taiwanese patients with moderate-to-severe plaque-type psorias…
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Randomized Study of PH-10 for Psoriasis [Phase 2]
This document reports the completion of a Phase 2 randomized study of PH-10 for psoriasis.
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis [Phase 3]
Phase 3 trial evaluating the safety and effectiveness of ustekinumab (Stelara) in Chinese patients with psoriasis. Results have been posted …
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)
A post-marketing surveillance study of infliximab (Remicade) in chronic inflammatory diseases has completed, with results posted in 2012. Th…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis [Phase 2]
Phase 2 trial update reports on the efficacy, safety, and tolerability of CEP-701 in patients with severe psoriasis.
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Can We Miss Pigmented Lesions in Psoriasis Patients? [Phase 4]
Phase 4 clinical trial assessing detection of pigmented lesions in psoriasis patients; completed with results posted in 2012.
-
FDA approval · 2012-08-17FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for CLOBEX (clobetasol propionate) submitted by Galderma Laboratories to update its labeling.
-
FDA approval · 2012-08-09FDA Approved: CLOBETASOL PROPIONATE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved the original application for clobetasol propionate topical product (a generic) from Padagis Israel Pharmaceuticals Ltd under AN…
-
CLINICAL_TRIALS research · 2012-08-06Clinical Trial Update: TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis [NA]
This clinical trial update reports on research examining how TNF-alpha inhibitors affect antibody production in psoriasis patients, with the…
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis [Phase 4]
A Phase 4 trial update reports long-term use (one year) of alefacept (Amevive) in moderate to severe chronic plaque psoriasis; results poste…